Safety and Efficacy of Bimatoprost Ophthalmic Solution in Increasing Eyelash Prominence

• Status: Completed
• Trial end date: 2010-07-01
• Target enrollment: 0
• Participant gender: Female

Summary

This study will evaluate the safety and efficacy of bimatoprost ophthalmic solution 0.005% or 0.015% compared with bimatoprost ophthalmic solution 0.03% once-daily application to the upper eyelid margins in increasing eyelash prominence

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Allergan
• Treatments: Bimatoprost; Ophthalmic Solutions; Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• Female Caucasians between 30 and 55 years of age, with hypotrichosis (inadequate or not enough) of the eyelashes

• Eyelash prominence assessment of minimal or moderate

Exclusion Criteria:

• Any eye disease or abnormality

• Any permanent eyeliner or eyelash implants of any kind

• Any ocular surgery, semi-permanent eyelash tint, or eyelash extension application during the 3 months prior to study entry

• Any use of prescription eyelash growth products

• Any use of over the counter eyelash growth products during the 6 months prior to baseline

• Any use of treatments that may affect hair growth during the 6 months prior to baseline